Mike Polark
Stock Analyst at Baird
(3.63)
# 833
Out of 5,091 analysts
79
Total ratings
50.98%
Success rate
7.92%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Outperform | $125 → $180 | $143.99 | +25.01% | 9 | Dec 4, 2025 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $84.32 | - | 5 | Oct 29, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $180 → $220 | $173.59 | +26.74% | 9 | Oct 10, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $101.26 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $28.31 | -29.35% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $62.67 | -4.26% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $296.19 | +18.17% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $24.53 | +18.22% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $250.04 | -28.01% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $92.75 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $353.60 | +14.54% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $566.89 | -11.27% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $122.09 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $119.82 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $65.62 | +84.40% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $20.74 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.60 | +50.60% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $140.85 | +17.15% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $93.84 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.46 | -21.00% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $4.95 | +324.24% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $261.41 | -4.36% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $0.80 | +5,282.40% | 1 | Sep 2, 2020 |
Inspire Medical Systems
Dec 4, 2025
Maintains: Outperform
Price Target: $125 → $180
Current: $143.99
Upside: +25.01%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $84.32
Upside: -
iRhythm Technologies
Oct 10, 2025
Maintains: Outperform
Price Target: $180 → $220
Current: $173.59
Upside: +26.74%
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $101.26
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $28.31
Upside: -29.35%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $62.67
Upside: -4.26%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $296.19
Upside: +18.17%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $24.53
Upside: +18.22%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $250.04
Upside: -28.01%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $92.75
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $353.60
Upside: +14.54%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $566.89
Upside: -11.27%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $122.09
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $119.82
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $65.62
Upside: +84.40%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $20.74
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.60
Upside: +50.60%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $140.85
Upside: +17.15%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $93.84
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $16.46
Upside: -21.00%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $4.95
Upside: +324.24%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $261.41
Upside: -4.36%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $0.80
Upside: +5,282.40%